PhD, 05/2019 - Genetics and Genomics, Duke University
MD, 06/2012 - Medicine, National Yang Ming University

Honors & Awards

  • 2022 – 2023
    Jonathan I. Epstein, M.D. Fellow, Johns Hopkins University
  • 2022
    Diversity, Equity, and Inclusion Research Award, American Society of Cytopathology
  • 2021
    Second place abstract award, International Association of Chinese Pathologists
  • 2012
    Chancellor’s Scholar, Duke University
  • 2011 – 2012
    Best Medical Intern of the Year, Taipei Veterans General Hospital, Taiwan
  • 2004
    Presidential Award, National Yang Ming University, Taiwan
  • 2003
    Silver Award, 14th International Biology Olympiad, Minsk, Belarus

Selected Publications

  1. Nguyen ED, Ding CC, Umetsu SE, Choi WT, Ferrell LD, Wen KW. Use of orcein as an adjunct stain in the evaluation of advanced liver fibrosis. Histopathology. 2023 Oct;83(4):538-545. doi: 10.1111/his.14962. Epub 2023 May 24. View on PubMed
  2. Khorsandi N, Ding CC, VandenBussche CJ, Verduzco CS, Greenland N, Vohra P. Urine cytology in patients with gender confirmation surgery and hormone therapy: evaluation of urine cytology performance in an underserved patient population. J Am Soc Cytopathol. 2023 Jul-Aug;12(4):267-274. doi: 10.1016/j.jasc.2023.04.001. Epub 2023 Apr 11. View on PubMed
  3. Sun T, Ding CC, Chi JT. Data on the transcriptional response to MESH1 knockdown and mammalian stringent response. Data Brief. 2023 Apr;47:108938. doi: 10.1016/j.dib.2023.108938. eCollection 2023 Apr. View on PubMed
  4. Baraban E, Ding CC, White M, Vohra P, Simko J, Boyle K, Guo C, Zhang M, Dobs A, Ketheeswaran S, Liang F, Epstein JI. Prostate Cancer in Male-to-Female Transgender Individuals: Histopathologic Findings and Association With Gender-affirming Hormonal Therapy. Am J Surg Pathol. 2022 Dec 1;46(12):1650-1658. doi: 10.1097/PAS.0000000000001964. Epub 2022 Aug 26. View on PubMed
  5. Neumann NM, Cornelia Ding CK, Borgen A, Corvera CU, North JP, Qorbani A, Horvai AE. Primary Cutaneous Malignant Perivascular Epithelioid Cell Tumor Mimicking Undifferentiated Pleomorphic Sarcoma: A Report of a Rare Entity. Am J Dermatopathol. 2022 Oct 1;44(10):768-773. doi: 10.1097/DAD.0000000000002241. Epub 2022 Jun 2. View on PubMed
  6. Ding CC, Chan S, Mak J, Umetsu SE, Simko JP, Ruiz-Cordero R, Saunders T, Chan E. An exploration in pitfalls in interpreting SDHB immunohistochemistry. Histopathology. 2022 Aug;81(2):264-269. doi: 10.1111/his.14681. Epub 2022 May 27. View on PubMed
  7. Sun T, Ding CC, Zhang Y, Zhang Y, Lin CC, Wu J, Setayeshpour Y, Coggins S, Shepard C, Macias E, Kim B, Zhou P, Gordân R, Chi JT. MESH1 knockdown triggers proliferation arrest through TAZ repression. Cell Death Dis. 2022 Mar 10;13(3):221. doi: 10.1038/s41419-022-04663-6. View on PubMed
  8. Lin CC, Ding CC, Sun T, Wu J, Chen KY, Zhou P, Chi JT. The regulation of ferroptosis by MESH1 through the activation of the integrative stress response. Cell Death Dis. 2021 Jul 22;12(8):727. doi: 10.1038/s41419-021-04018-7. View on PubMed
  9. Lin CC, Yang WH, Lin YT, Tang X, Chen PH, Ding CC, Qu DC, Alvarez JV, Chi JT. DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway. Oncogene. 2021 Mar;40(11):2018-2034. doi: 10.1038/s41388-021-01676-x. Epub 2021 Feb 18. View on PubMed
  10. Chen PH, Wu J, Xu Y, Ding CC, Mestre AA, Lin CC, Yang WH, Chi JT. Zinc transporter ZIP7 is a novel determinant of ferroptosis. Cell Death Dis. 2021 Feb 19;12(2):198. doi: 10.1038/s41419-021-03482-5. View on PubMed
  11. Chang WC, M Yeh B, Chu L, Kim SY, Wen KW, Chiu SH, Ding CC, Wu EH, Roberts JP, Huang GS, Hsu HH. Post-operative assessment in patients after liver transplantation: imaging parameters associated with 1-year graft failure. Eur Radiol. 2021 Feb;31(2):764-774. doi: 10.1007/s00330-020-07124-w. Epub 2020 Aug 30. View on PubMed
  12. Ding CC, Rose J, Sun T, Wu J, Chen PH, Lin CC, Yang WH, Chen KY, Lee H, Xu E, Tian S, Akinwuntan J, Zhao J, Guan Z, Zhou P, Chi JT. MESH1 is a cytosolic NADPH phosphatase that regulates ferroptosis. Nat Metab. 2020 Mar;2(3):270-277. doi: 10.1038/s42255-020-0181-1. Epub 2020 Mar 9. View on PubMed
  13. Chen PH, Wu J, Ding CC, Lin CC, Pan S, Bossa N, Xu Y, Yang WH, Mathey-Prevot B, Chi JT. Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism. Cell Death Differ. 2020 Mar;27(3):1008-1022. doi: 10.1038/s41418-019-0393-7. Epub 2019 Jul 18. View on PubMed
  14. Yang WH, Huang Z, Wu J, Ding CC, Murphy SK, Chi JT. A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer. Mol Cancer Res. 2020 Jan;18(1):79-90. doi: 10.1158/1541-7786.MCR-19-0691. Epub 2019 Oct 22. View on PubMed
  15. Yang WH, Ding CC, Sun T, Rupprecht G, Lin CC, Hsu D, Chi JT. The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma. Cell Rep. 2019 Sep 3;28(10):2501-2508.e4. doi: 10.1016/j.celrep.2019.07.107. View on PubMed
  16. Tang X, Ding CC, Wu J, Sjol J, Wardell S, Spasojevic I, George D, McDonnell DP, Hsu DS, Chang JT, Chi J. Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling. Oncogene. 2017 July; 36(30):4235. View on PubMed
  17. Tang X, Wu J, Ding CK, Lu M, Keenan MM, Lin CC, Lin CA, Wang CC, George D, Hsu DS, Chi JT. Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas. Cancer Res. 2016 Apr 1;76(7):1892-903. doi: 10.1158/0008-5472.CAN-15-2328. Epub 2016 Feb 1. View on PubMed
  18. LaGory EL, Wu C, Taniguchi CM, Ding CC, Chi JT, von Eyben R, Scott DA, Richardson AD, Giaccia AJ. Suppression of PGC-1α Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma. Cell Rep. 2015 Jul 7;12(1):116-127. doi: 10.1016/j.celrep.2015.06.006. Epub 2015 Jun 25. View on PubMed
  19. Keenan MM, Ding CK, Chi JT. An unexpected alliance between stress responses to drive oncogenesis. Breast Cancer Res. 2014 Nov 6;16(6):471. doi: 10.1186/s13058-014-0471-1. View on PubMed
  20. Markunas CA, Lock E, Soldano K, Cope H, Ding CK, Enterline DS, Grant G, Fuchs H, Ashley-Koch AE, Gregory SG. Identification of Chiari Type I Malformation subtypes using whole genome expression profiles and cranial base morphometrics. BMC Med Genomics. 2014 Jun 25;7:39. doi: 10.1186/1755-8794-7-39. View on PubMed

Go to UCSF Profiles, powered by CTSI